{"database": "lobbying", "table": "lobbying_activities", "rows": [[1412684, "57106e4a-4b52-40ff-9ee6-8ee4dfc1ab9c", "Q2", "O'NEILL AND ASSOCIATES", 73134, "THE JETT FOUNDATION", 2013, "second_quarter", "MED", "FDA Issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2013-07-18T12:39:10.387000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1412684"], "units": {}, "query_ms": 30.21916514262557, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}